Hideyuki Ohshimo
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
-
- Gastric Cancer Management and Outcomes
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 15
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 6
-
- Lung Cancer Treatments and Mutations 5
- Gastric Cancer Management and Outcomes 5
- Co-authors
- Masakazu Fukushima (11 shared papers)Tetsuhiko Shirasaka (9 shared papers)Toshiyuki Kato (5 shared papers)Masahiro Yamaguchi (1 shared paper)Kazuhiko Yonekura (1 shared paper)Yuji Shimamoto (9 shared papers)Tomohiro Emura (4 shared papers)Norihiko Suzuki (2 shared papers)
In The Last Decade
Hideyuki Ohshimo
17 papers receiving 1.4k citations
Hideyuki Ohshimo's Hit Papers
Peers
Comparison fields: 5 of 66
- Oncology 737
- Pulmonary and Respiratory Medicine 498
- Otorhinolaryngology 52
- Hepatology 77
- Gastroenterology 47
Countries citing papers authored by Hideyuki Ohshimo
This map shows the geographic impact of Hideyuki Ohshimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Ohshimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Ohshimo more than expected).
Fields of papers citing papers by Hideyuki Ohshimo
This network shows the impact of papers produced by Hideyuki Ohshimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Ohshimo. The network helps show where Hideyuki Ohshimo may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideyuki Ohshimo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Hit paper breakdown → | 1996 | 711 |
| 2 | 1993 | 127 | |
| 3 | 2004 | 98 | |
| 4 | 1998 | 95 | |
| 5 | 2004 | 72 | |
| 6 | 2005 | 65 | |
| 7 | 1998 | 43 | |
| 8 | Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil. | 2001 | 32 |
| 9 | 1989 | 30 | |
| 10 | 1989 | 23 | |
| 11 | 2001 | 19 | |
| 12 | 2004 | 17 | |
| 13 | 2005 | 13 | |
| 14 | [Mechanism for synergistic antitumor effect in the combination of 5-fluorouracil with cisplatin in vivo tumor models: from the view of biochemical modulation of 5-fluorouracil]. | 1991 | 12 |
| 15 | [Metabolic characteristics and antitumor activity of BOF-A2, a new 5-fluorouracil derivative]. | 1990 | 5 |
| 16 | [Antimetastatic and antitumor effects of fluoropyrimidines alone and combined with taxanes in a murine model of breast cancer metastatic to the lung]. | 2002 | 4 |
| 17 | Effect of combination therapy with UFT plus cisplatin (UFTP) on the survival of mice in the experimental model for wide-spread metastasis in the peritoneal cavity of gastrointestinal cancer using colon 26 PMF-15 cells. | 1997 | 3 |
About Hideyuki Ohshimo
Hideyuki Ohshimo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Genetics, having authored 17 papers that have together received 1.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers), Gastric Cancer Management and Outcomes (5 papers), Biochemical and Molecular Research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Intraperitoneal and Appendiceal Malignancies (1 paper). The work is most often cited by research in Oncology (737 citations), Pulmonary and Respiratory Medicine (498 citations), Otorhinolaryngology (52 citations), Hepatology (77 citations) and Gastroenterology (47 citations). Hideyuki Ohshimo has collaborated with scholars based in Japan and Spain. Frequent co-authors include Masakazu Fukushima, Tetsuhiko Shirasaka, Toshiyuki Kato, Masahiro Yamaguchi, Kazuhiko Yonekura, Yuji Shimamoto, Tomohiro Emura, Norihiko Suzuki, Akio Fujioka and Hiroko Saito. Their work appears in journals such as International Journal of Oncology, Oncology Reports, Anti-Cancer Drugs, Cancer Chemotherapy and Pharmacology and International Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.